Edwards Lifesciences SG&A Expense (Quarterly) Insights

Edwards Lifesciences Corp (EW)

88.61 +0.86 (+0.98%) USD | NYSE | Apr 24, 16:00

87.15 -1.46 (-1.65%) Pre-Market: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2000. Upgrade now.

Date	Value
December 31, 2023	478.80M
September 30, 2023	439.60M
June 30, 2023	468.70M
March 31, 2023	436.30M
December 31, 2022	409.90M
September 30, 2022	377.30M
June 30, 2022	409.00M
March 31, 2022	370.30M
December 31, 2021	424.30M
September 30, 2021	364.40M
June 30, 2021	374.50M
March 31, 2021	330.80M
December 31, 2020	338.50M
September 30, 2020	307.20M
June 30, 2020	274.90M
March 31, 2020	307.80M
December 31, 2019	347.20M
September 30, 2019	306.20M
June 30, 2019	308.50M
March 31, 2019	280.30M
December 31, 2018	288.10M
September 30, 2018	269.50M
June 30, 2018	274.90M
March 31, 2018	256.00M
December 31, 2017	272.80M

Date	Value
September 30, 2017	244.60M
June 30, 2017	243.80M
March 31, 2017	229.60M
December 31, 2016	233.60M
September 30, 2016	229.60M
June 30, 2016	228.80M
March 31, 2016	212.70M
December 31, 2015	222.30M
September 30, 2015	212.00M
June 30, 2015	213.90M
March 31, 2015	202.50M
December 31, 2014	223.10M
September 30, 2014	222.20M
June 30, 2014	215.50M
March 31, 2014	197.20M
December 31, 2013	186.60M
September 30, 2013	177.80M
June 30, 2013	186.60M
March 31, 2013	182.40M
December 31, 2012	170.00M
September 30, 2012	167.80M
June 30, 2012	182.40M
March 31, 2012	177.20M
December 31, 2011	163.40M
September 30, 2011	165.50M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

274.90M

Minimum

Jun 2020

478.80M

Maximum

Dec 2023

372.33M

Average

370.30M

Median

Mar 2022

SG&A Expense (Quarterly) Benchmarks